Theravance Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TBPH and other ETFs, options, and stocks.

About TBPH

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the following geographical segments: U.S. and Europe. 

CEO
Rick E. Winningham
CEORick E. Winningham
Employees
90
Employees90
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2013
Founded2013
Employees
90
Employees90

TBPH Key Statistics

Market cap
877.97M
Market cap877.97M
Price-Earnings ratio
7.68
Price-Earnings ratio7.68
Dividend yield
Dividend yield
Average volume
1.32M
Average volume1.32M
High today
$17.02
High today$17.02
Low today
$16.93
Low today$16.93
Open price
$17.01
Open price$17.01
Volume
1.51M
Volume1.51M
52 Week high
$21.03
52 Week high$21.03
52 Week low
$10.82
52 Week low$10.82

Stock Snapshot

With a market cap of 877.97M, Theravance Biopharma(TBPH) trades at $16.93. The stock has a price-to-earnings ratio of 7.68.

On 2026-07-05, Theravance Biopharma(TBPH) stock traded between a low of $16.93 and a high of $17.02. Shares are currently priced at $16.93, which is 0.0% above the low and -0.5% below the high.

Theravance Biopharma(TBPH) shares are trading with a volume of 1.51M, against a daily average of 1.32M.

During the past year, Theravance Biopharma(TBPH) stock moved between $10.82 at its lowest and $21.03 at its peak.

During the past year, Theravance Biopharma(TBPH) stock moved between $10.82 at its lowest and $21.03 at its peak.

TBPH News

TipRanks 3d
Major Insider Move Rocks Theravance Biopharma Shares

New insider activity at Theravance Biopharma ( (TBPH) ) has taken place on July 1, 2026. End of Quarter Sale - 70% Off Unlock powerful investing tools and data-...

TipRanks 6d
Theravance Biopharma downgraded to Neutral from Buy at BTIG

BTIG downgraded Theravance Biopharma (TBPH) to Neutral from Buy after Zymeworks (ZYME) announced it has agreed to acquire the company for $17 per share. The fir...

Barron's 6d
Why This Biotech Stock Is Falling After a $929 Million Buyout Lifeline

Biotech and Pharma Why This Biotech Stock Is Falling After a $929 Million Buyout Lifeline In this article TBPH ZYME Zymeworks has agreed to acquire Theravance B...

Why This Biotech Stock Is Falling After a $929 Million Buyout Lifeline

More TBPH News

TipRanks 6d
Theravance Biopharma to be Acquired by Zymeworks

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

People also own

Based on the portfolios of people who own TBPH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.